Lumen bioscience, INC. Intranasal antibody cocktail delivery platform AOI #6 beyond the needle
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00025
- Awardee
-
Lumen Bioscience, Inc. UEI E9UJDT3BFUQ5
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $703,000
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $703,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 50 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98103, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $703,000 |
About this award
Lumen Bioscience, Inc. received a $703,000 firm fixed-price contract from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an intranasal antibody cocktail delivery platform. The contract, awarded on April 11, 2022, with a completion date of April 30, 2023, supports the government's "Beyond the Needle" initiative focused on alternative drug delivery mechanisms. Work will be performed in Seattle, Washington. This contract represents no set-aside designation and is part of the agency's broader mission to enhance public health preparedness and response capabilities.
Lumen Bioscience is a biotechnology company specializing in developing biologic drugs and therapeutic delivery platforms using proprietary platform organisms. The intranasal antibody delivery platform developed under this contract aligns with the Office of the Assistant Secretary for Preparedness and Response's focus on medical countermeasures and mitigation of respiratory health threats. The company's experience in federal contracting and grants, including work on vaccine development and anti-infective therapeutics, positions it to deliver innovative solutions that advance the government's preparedness objectives beyond traditional needle-based delivery methods.
Quick answers
Who was awarded contract 75A50122C00025?
75A50122C00025 was awarded to Lumen Bioscience, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on April 11, 2022.
How much is contract 75A50122C00025 worth?
The government has obligated $703,000 on 75A50122C00025.
Was contract 75A50122C00025 competed?
The extent of competition for 75A50122C00025 was full and open competition. The government received 50 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award